Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Total Costs & Expenses

₹297.64B

TTM · Period ending: · INR

RDY logo

RDY Total Costs & Expenses

Latest reported₹297.64B INR
RDY TTM Total Costs & Expenses · INR (₹14.14B → ₹297.64B)
High-resolution chart · PNG

RDY total costs & expenses history

Trailing twelve months (TTM) · INR. Each value covers four complete reported quarters.

Dr. Reddy's Laboratories Ltd Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (INR)
Period endingTotal Costs & Expenses (INR)
297,638,390,000
287,403,142,000
278,958,000,000
270,794,000,000
262,867,000,000
253,692,000,000
242,150,000,000
232,165,000,000
170,210,474,664
161,156,474,664
105,897,399,469
102,225,399,469
102,160,832,142
92,375,832,142
92,370,293,576
85,101,293,576
85,147,252,052
87,800,252,052
87,747,730,346
90,904,730,346
90,804,549,488
84,255,549,488
121,410,684,955
74,828,898,081
114,998,213,126
109,427,213,126
106,539,213,126
138,795,000,000
131,492,000,000
133,503,000,000
131,384,000,000
131,664,000,000
129,918,000,000
130,113,000,000
129,818,000,000
128,061,000,000
128,872,000,000
127,323,000,000
127,406,000,000
128,212,000,000
126,379,000,000
125,066,000,000
125,160,000,000
124,264,000,000
123,042,000,000
121,862,000,000
118,231,000,000
114,249,000,000
111,049,000,000
106,695,000,000
103,713,000,000
100,407,000,000
97,072,000,000
94,251,000,000
89,653,000,000
85,882,000,000
81,936,000,000
77,445,000,000
72,402,000,000
68,309,000,000
64,853,000,000
62,065,000,000
60,047,000,000
58,634,000,000
58,981,000,000
59,704,000,000
60,689,000,000
60,698,000,000
59,259,459,000
57,770,459,000
54,437,059,540
53,392,164,326
49,517,834,673
46,014,289,244
46,213,613,574
45,974,582,680
51,573,387,617
53,890,391,443
48,984,841,036
40,797,497,190
29,741,054,840
22,782,552,858
21,723,953,220
20,972,962,215
20,851,580,412
20,619,244,522
19,513,845,122
19,651,074,071
19,143,265,961
18,068,599,103
16,643,842,022
15,809,986,687
15,386,892,499
14,700,454,708
14,136,527,317
13,486,161,580
12,372,867,067
11,551,561,051
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.